M&T BANK CORP
Company Information
Industry
State Commercial Banks
SIC Code
6022
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
NY
Business Address
C/O LEGAL, BUFFALO, NY, 14203
Mailing Address
C/O LEGAL, BUFFALO, NY, 14203
Phone
7165593172
Fiscal Year End
1231
EIN
160968385
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
Annual Reports
10-K
February 18, 2026
- Strong financial performance in 2025 with 5% revenue growth to $9.2 billion and 8% net income growth to $3.1 billion.
- Robust capital position with a CET1 ratio of 10.8% and total shareholder equity of $28 billion.
Insider Trading
STRONG SELL
6 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 6022)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.